Brian Anderson
Plus aucun poste en cours
Profil
Brian Anderson served as President & Chief Executive Officer at Cognetix, Inc. from 2002 to 2002.
He was also a Director at Oragenics, Inc. and Omni Genetics, Inc. Anderson served as Independent Director at PolyMedix, Inc. from 2008 to 2013.
He was Principal at Alkermes, Inc. in 2007 and Chief Business Officer at MediciNova, Inc. in 2005.
Anderson was Senior Vice President-Commercial Development at Indevus Pharmaceuticals, Inc. from 1998 to 1998.
He earned an undergraduate degree from the University of Manitoba.
Anciens postes connus de Brian Anderson
Sociétés | Poste | Fin |
---|---|---|
POLYMEDIX, INC. | Directeur/Membre du Conseil | 01/04/2013 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/03/2007 |
ORAGENICS, INC. | Directeur/Membre du Conseil | 05/05/2006 |
MEDICINOVA, INC. | Corporate Officer/Principal | 01/09/2005 |
Cognetix, Inc.
Cognetix, Inc. Drugstore ChainsRetail Trade Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT | President | 01/01/2002 |
Formation de Brian Anderson
University of Manitoba | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ORAGENICS, INC. | Health Technology |
MEDICINOVA, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Cognetix, Inc.
Cognetix, Inc. Drugstore ChainsRetail Trade Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT | Retail Trade |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
Omni Genetics, Inc.
Omni Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Omni Genetics, Inc. provides biological research services in genome-wide SNP discovery and genotyping technologies. The company focuses on to identify genes and mutations underlying multifactorial disease, assist partners in drug development through science and technology. Omni Genetics is located in Menlo Park, CA | Commercial Services |
PolyMedix, Inc.
PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |